Cancer immunotherapy is a kind of cancer treatment that mobilizes the patient’s immune defenses to recognize and attack tumor cells. It is now the treatment of choice for many patients with advanced melanoma, according to Elizabeth I. Buchbinder, MD, a melanoma specialist at Dana-Farber.
“Immunotherapy has taken off,” Buchbinder says, “There are tons of areas where it is being developed, as well as some where it really has entered into the mainstream for cancer care.”
Buchbinder is interested in the potential of using immunotherapy to prevent reoccurrence of melanoma in patients.
“This is an area that’s very active right now,” Buchbinder says, “We’re really hopeful that we can use these drugs to lower the risk of melanoma coming back.”
Buchbinder discussed other developments in immunotherapy research and melanoma in a recent Facebook Live webchat. View the video below.
Learn more about melanoma treatment and research from the Center for Melanoma Oncology at Dana Farber/Brigham and Women’s Cancer Center.